Original Research

Published on 22 Jul 2021

Developmental Alcohol Exposure in Drosophila: Effects on Adult Phenotypes and Gene Expression in the Brain

in Psychopharmacology

Sneha S. Mokashi
Vijay Shankar
Rebecca A. MacPherson
Rachel C. Hannah
Trudy F. C. Mackay
Robert R. H. Anholt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.699033

5,416 views
18 citations

Hypothesis and Theory

Published on 19 Jul 2021

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

in Psychopharmacology

Rita Kočárová
Jiří Horáček
Robin Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.661233

17,941 views
53 citations

Original Research

Published on 16 Jul 2021

Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor

in Psychopharmacology

Xuan Ju
Shengdong Wang
Pan Yan
Chunyan Zhu
Xiwen Hu
Jiezheng Dong
Zhonglin Tan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.599399

4,280 views
10 citations

Brief Research Report

Published on 05 Jul 2021

Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication

in Psychopharmacology

Guoying Wang
Wolfgang Weber-Fahr
Ulrich Frischknecht
Derik Hermann
Falk Kiefer
Gabriele Ende
Markus Sack

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.656468

5,733 views
9 citations

Hypothesis and Theory

Published on 29 Jun 2021

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model

in Psychopharmacology

Ahmet Yardimci
Mehmet Ridvan Ozdede
Haluk Kelestimur

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.654616

12,887 views
7 citations

Original Research

Published on 29 Jun 2021

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

in Psychopharmacology

Keri Mans
Hannes Kettner
David Erritzoe
Eline C. H. M. Haijen
Mendel Kaelen
Robin L. Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.647909

20,178 views
36 citations

Original Research

Published on 25 Jun 2021

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis

in Psychopharmacology

Ken Kurisu
Kazuhiro Yoshiuchi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.609678

23,108 views
4 citations

Original Research

Published on 25 Jun 2021

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

in Psychopharmacology

Sophie Lonchampt
Fabienne Gerber
Jean-Michel Aubry
Jules Desmeules
Markus Kosel
Marie Besson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.614825

6,275 views
7 citations

Original Research

Published on 16 Jun 2021

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study

in Psychopharmacology

Dóra Révész
Genís Ona
Giordano N. Rossi
Juliana M. Rocha
Rafael G. dos Santos
Jaime E. C. Hallak
Miguel Á. Alcázar-Córcoles
José C. Bouso

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.687546

10,958 views
30 citations

Original Research

Published on 15 Jun 2021

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial

in Psychopharmacology

Wolfgang Marx
David R. Skvarc
Mohammadreza Mohebbi
Adam J. Walker
Alcy Meehan
Alyna Turner
Andrea Baker
Seetal Dodd
Sue M. Cotton
James Graham Scott

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.626486

3,319 views
3 citations

Clinical Trial

Published on 02 Jun 2021

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study

in Psychopharmacology

Zhengchao Dong
Michael F. Grunebaum
Martin J. Lan
Vashti Wagner
Tse-Hwei Choo
Matthew S. Milak
Tarek Sobeih
J. John Mann
Joshua T. Kantrowitz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.653026

5,080 views
10 citations

Mini Review

Published on 01 Jun 2021

The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future

in Psychopharmacology

Martie Van Der Walt
Karen H. Keddy

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.617751

11,693 views
9 citations

Original Research

Published on 31 May 2021

We Have a Lot to Do: Lack of Sexual Protection and Information—Results of the German-Language Online Survey “Let's Talk About Chemsex”

in Psychopharmacology

Cornelia Rosenberger
Marcus Gertzen
Moritz Strasburger
Johanna Schwarz
Solveig Gernun
Andrea Rabenstein
Eva Lermer
Tobias Rüther

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.690242

4,427 views
13 citations

Hypothesis and Theory

Published on 26 May 2021

Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis

in Psychopharmacology

Peter Sjöstedt
Jesper Enander
Josef Isung

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.682868

88,028 views
30 citations

Original Research

Published on 26 May 2021

Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea

in Psychopharmacology

Soo Min Jeon
Susan Park
Soonhak Kwon
Jin-Won Kwon

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.668704

5,787 views
6 citations

Case Report

Published on 12 May 2021

Case Report: Treatment of a Comorbid Attention Deficit Hyperactivity Disorder and Obsessive–Compulsive Disorder With Psychostimulants

in Psychopharmacology

Ezgi Dogan-Sander
Maria Strauß

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.649833

13,848 views
4 citations

Navigation group

Articles

Developmental Alcohol Exposure in Drosophila: Effects on Adult Phenotypes and Gene Expression in the Brain

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor

Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial

Relationship of Brain Glutamate Response to D-Cycloserine and Lurasidone to Antidepressant Response in Bipolar Depression: A Pilot Study

The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future

We Have a Lot to Do: Lack of Sexual Protection and Information—Results of the German-Language Online Survey “Let's Talk About Chemsex”

Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis

Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea

Case Report: Treatment of a Comorbid Attention Deficit Hyperactivity Disorder and Obsessive–Compulsive Disorder With Psychostimulants